Fish Oil Prevents Lipopolysaccharide-Induced Depressive-Like Behavior by Inhibiting Neuroinflammation.
Level 5 - mechanism / opinion, no new human data
Animal research without human data
PubMed 27815837 · doi:10.1007/s12035-016-0212-9
What was done
Mice were pretreated with fish oil prior to systemic lipopolysaccharide (LPS) injection to induce acute depressive-like behaviors. The investigators measured cytokine and stress hormone levels in plasma, adrenal glands, the hypothalamus, and various other brain regions, alongside behavioral assessments.
What was found
No quantitative values, sample sizes, or p-values are reported in the abstract. The authors report that fish oil pretreatment prevented LPS-induced depressive-like behavior and prevented acute neuroinflammation across different brain regions, while neither LPS nor fish oil had a strong effect on hypothalamic or adrenal stress hormone secretion.
Why it matters
This study provides preclinical mechanistic evidence that omega-3 fatty acids may protect against acute endotoxin-induced neuroinflammation and associated behavioral changes.
Limits
Findings are limited to an animal model using an acute toxin-induced paradigm that does not fully model human clinical depression. The abstract does not report sample sizes, specific fish oil doses or compositions, duration of treatment, or numerical outcome metrics.
Cited by
- supports Pretreatment with high-dose EPA omega-3 fatty acids prevents the development of depressive symptoms induced by lipopolysaccharide injection in healthy individuals.